1.80
Protalix BioTherapeutics Inc. Aktie (PLX) Neueste Nachrichten
Protalix, Secarna in agreement to develop rare kidney disorder therapies - MSN
Small cap wrap: Tiziana Life Sciences, NanoViricides, 1911 Gold, Protalix BioTherapeutics… - Proactive Investors
Protalix and Secarna partner to develop rare kidney disease treatments By Investing.com - Investing.com Nigeria
Protalix BioTherapeutics (PLX) Partners with Secarna for Kidney Disorder Treatments - GuruFocus
Protalix BioTherapeutics partners with Secarna Pharmaceuticals on rare kidney disease drug development - Proactive financial news
Protalix Partners With Secarna to Jointly Develop Therapies for Rare Renal Indications - marketscreener.com
Protalix and Secarna partner to develop rare kidney disease treatments - Investing.com
Protalix Biotherapeutics and Secarna Pharmaceuticals enter into collaboration and option agreement - marketscreener.com
Protalix Biotherapeutics and Secarna Pharmaceuticals Enter into Collaboration and Option Agreement - PR Newswire
Protalix BioTherapeutics (PLX) Price Target Decreased by 10.71% to 12.75 - Nasdaq
Why analysts recommend Protalix BioTherapeutics Inc. (PBDA) stockJuly 2025 Selloffs & Detailed Earnings Play Strategies - Newser
Will Protalix BioTherapeutics Inc. (PBDA) stock rise with strong economy2025 Analyst Calls & Capital Protection Trading Alerts - Newser
How Protalix BioTherapeutics Inc. (DE) stock performs in volatility spikes2025 Short Interest & Growth Oriented Trading Recommendations - Newser
Why global investors buy Protalix BioTherapeutics Inc. (DE) stockMarket Sentiment Summary & Technical Entry and Exit Tips - Newser
Is Protalix BioTherapeutics Inc. (PBDA) stock a contrarian opportunity - Newser
Will Protalix BioTherapeutics Inc. (DE) stock split increase liquidityJuly 2025 Snapshot & Low Drawdown Momentum Trade Ideas - Newser
Why Protalix BioTherapeutics Inc. (DE) stock attracts wealthy investors2025 Market Trends & Scalable Portfolio Growth Methods - Newser
Is Protalix BioTherapeutics Inc. (DE) stock supported by strong fundamentals2025 Volume Leaders & Technical Confirmation Trade Alerts - Newser
How Protalix BioTherapeutics Inc. (PBDA) stock behaves under inflation pressure2025 Bull vs Bear & Verified Entry Point Detection - Newser
How Protalix BioTherapeutics Inc. (PBDA) stock compares with top peersJuly 2025 Selloffs & Short-Term High Return Ideas - Newser
Protalix BioTherapeutics (PLX) Stock Analysis Report | Financials & Insights - Benzinga
Will Protalix BioTherapeutics Inc. (DE) stock test record highs in 2025Weekly Trade Recap & Risk Controlled Swing Alerts - Newser
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Sentiment Watch: Is Protalix BioTherapeutics Inc. stock attractive for hedge fundsCPI Data & AI Based Buy and Sell Signals - moha.gov.vn
Protalix BioTherapeutics Inc. R (PBDA.F) Q1 FY2025 earnings call transcript - Yahoo Finance
Protalix BioTherapeutics Inc. R (PBDA.F) Q2 FY2025 earnings call transcript - Yahoo Finance
Research Analysts Set Expectations for PLX FY2025 Earnings - Defense World
HC Wainwright Lowers Protalix BioTherapeutics (NYSE:PLX) Price Target to $12.00 - Defense World
PLX Analyst Forecasts - Quiver Quantitative
Protalix BioTherapeutics (PLX) Price Target Lowered by HC Wainwr - GuruFocus
HC Wainwright & Co. Maintains Protalix BioTherapeutics (PLX) Buy Recommendation - Nasdaq
Can Protalix BioTherapeutics Inc. (PBDA) stock sustain double digit ROEJuly 2025 Pullbacks & Weekly High Conviction Trade Ideas - newser.com
Is Protalix BioTherapeutics Inc. stock undervalued vs historical averagesQuarterly Profit Summary & Long Hold Capital Preservation Tips - newser.com
Zacks Small Cap Has Bearish Outlook for PLX FY2025 Earnings - Defense World
What RSI levels show for Protalix BioTherapeutics Inc. (PBDA) stockJuly 2025 Fed Impact & Advanced Technical Signal Analysis - newser.com
Will Protalix BioTherapeutics Inc. stock maintain dividend yieldJuly 2025 Decliners & Daily Entry Point Alerts - newser.com
PLX: Protalix Seeks Re-Examination of CHMP Opinion - MSN
How to integrate Protalix BioTherapeutics Inc. into portfolio analysis toolsEarnings Summary Report & Safe Capital Growth Stock Tips - newser.com
[Form 4] Protalix BioTherapeutics, Inc. Insider Trading Activity - Stock Titan
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):